CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s

Group 2 innate lymphoid cells (ILC2s) are critical for the immune response against parasite infection and tissue homeostasis and involved in the pathogenesis of allergy and inflammatory diseases. Although multiple molecules positively regulating ILC2 development and activation have been extensively investigated, the factors limiting their population size and response remain poorly studied. Here, we found that CD45, a membrane-bound tyrosine phosphatase essential for T cell development, negatively regulated ILC2s in a cell-intrinsic manner. ILC2s in CD45-deficient mice exhibited enhanced proliferation and maturation in the bone marrow and hyperactivated phenotypes in the lung with high glycolytic capacity. Furthermore, CD45 signaling suppressed the type 2 inflammatory response by lung ILC2s and alleviated airway inflammation and pulmonary fibrosis. Finally, the interaction with galectin-9 influenced CD45 signaling in ILC2s. These results demonstrate that CD45 is a cell-intrinsic negative regulator of ILC2s and prevents lung inflammation and fibrosis via ILC2s.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:120

Enthalten in:

Proceedings of the National Academy of Sciences of the United States of America - 120(2023), 36 vom: 05. Sept., Seite e2215941120

Sprache:

Englisch

Beteiligte Personen:

Cui, Guangwei [VerfasserIn]
Shimba, Akihiro [VerfasserIn]
Jin, Jianshi [VerfasserIn]
Hojo, Nozomi [VerfasserIn]
Asahi, Takuma [VerfasserIn]
Abe, Shinya [VerfasserIn]
Ejima, Aki [VerfasserIn]
Okada, Shinri [VerfasserIn]
Ohira, Keizo [VerfasserIn]
Kato, Ryoma [VerfasserIn]
Tani-Ichi, Shizue [VerfasserIn]
Yamada, Ryo [VerfasserIn]
Ebihara, Takashi [VerfasserIn]
Shiroguchi, Katsuyuki [VerfasserIn]
Ikuta, Koichi [VerfasserIn]

Links:

Volltext

Themen:

Airway inflammation
CD45
Fibrosis
Innate lymphoid cell
Journal Article
Metabolism
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 31.08.2023

Date Revised 29.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1073/pnas.2215941120

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361376820